Benefit of Lidocaine Perfusion in Cancer Related Visceral Pain Resistant to Morphinics
Phase 3
- Conditions
- CancerPain
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2007-09-19
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 100
- Registration Number
- NCT00181012
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood
Phase 2
- Conditions
- MedulloblastomaBrain TumorsNeuroectodermal Tumors, Primitive
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2007-09-18
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 71
- Registration Number
- NCT00180791
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Analgesia of Fibula Free Flap Donor Site by Peri-Neuronal Catheter in Oro-Pharyngeal Carcinoma Surgery
Phase 3
- Conditions
- Oropharyngeal Neoplasms
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2007-08-28
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 40
- Registration Number
- NCT00181038
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia
Phase 2
Terminated
- Conditions
- Colon TumorsRectum TumorsAppendix TumorsPeritoneum TumorsEndocrine Tumors
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 100
- Registration Number
- NCT00180960
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
Glivec Phase II Pediatric Study
Phase 2
Terminated
- Conditions
- Cancer
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 36
- Registration Number
- NCT00180830
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
π³π±Emma Kinderziekenhuis AMC, Amsterdam, Netherlands
π¬π§Birmingham Children's Hospital, Birmingham, United Kingdom
LMBA02 Protocol for Patients With a Burkitt Lymphoma
Phase 3
- Conditions
- Burkitt Lymphoma
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 260
- Registration Number
- NCT00180882
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL
Phase 2
Terminated
- Conditions
- Burkitt Lymphoma
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-09-11
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 40
- Registration Number
- NCT00180895
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse
Phase 2
- Conditions
- RhabdomyosarcomasNeoplasms, Connective and Soft TissueEwing TumorOsteosarcomasNeuroblastomasMedulloblastomas
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2006-09-08
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 210
- Registration Number
- NCT00180947
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area
Phase 3
- Conditions
- Recurrence of Head and Cancer in Irraiated Area
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2005-12-23
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 280
- Registration Number
- NCT00180934
- Locations
- π«π·
Institut Gustave Roussy, Villejuif, France
Randomized Trial Of Platelet Transfusion Policies After Blood Stem Cells Transplantation In Young Children: Reduction Of Number Of Single Platelet Concentrate Donors Per Child
Phase 3
- Conditions
- Children Treated With High-Dose Chemotherapy (HDC) Followed by Haematopoietic Stem Cell Transplantation (HSCT)
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2005-12-14
- Lead Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Target Recruit Count
- 120
- Registration Number
- NCT00180986
- Locations
- π«π·
Institut Gustave-Roussy, Villejuif, France
Β© Copyright 2025. All Rights Reserved by MedPath